Showing results (581-590 of 1,007) with videos related to

Sort By:
Pageof 101
Journal of Parkinson'S Disease|August 5, 2017
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety StudyRobert A Hauser, Rajesh Pahwa, Caroline M Tanner, et al.
Gene|September 30, 1991
Plasmids for recombination-based screeningG D Stewart, M A Hauser, H Kang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 17, 2013
Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's diseaseStewart A Factor, Kenneth Wolski, Daniel M Togasaki, et al.
The Lancet. Neurology|March 15, 2013
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trialRobert A Hauser, Ann Hsu, Sherron Kell, et al.
Pediatrics|June 1, 1990
Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective studyS Shinnar, A T Berg, S L Moshé, et al.
Bulletin of Environmental Contamination and Toxicology|February 16, 2018
Correction to: Cryptosporidium Spp. Contamination in Perna perna Mussels Destined for Human Consumption in Southeastern Rio de Janeiro, BrazilA L Santos, L T F de Oliveira, A L A Souza, et al.
Human Genetics|April 17, 2003
Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorderFiona C Crawford, Ghania Ait-Ghezala, Mark Morris, et al.
Journal of the American Society of Nephrology : JASN|August 24, 2001
An increase in myeloid-related protein serum levels precedes acute renal allograft rejectionKlaus Burkhardt, Martin Radespiel-Tröger, Harald D Rupprecht, et al.
Neurology|June 30, 2012
Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study)Peter A Lewitt, Robert A Hauser, Mei Lu, et al.
Vaccines|September 28, 2023
Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis PatientsEugen Ovcar, Sammy Patyna, Niko Kohmer, et al.
Pageof 101